Screener
Dianthus Therapeutics DNTH Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Dianthus Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Dianthus Therapeutics’s 10-Q, filed November 5, 2025. Open the filing →
- Filed
- Nov 5, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-266920
FAQ
- What is Dianthus Therapeutics's free cash flow margin?
- Dianthus Therapeutics (DNTH) reported free cash flow margin of -3,561.6% in Q3 2025.
- How has Dianthus Therapeutics's free cash flow margin changed year-over-year?
- Dianthus Therapeutics's free cash flow margin decreased by 204.9% year-over-year, from -1,168% to -3,561.6%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Dianthus Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude